Pohunek, P. and Scuri, M. and Reznichenko, Y. and Varoli, G. and Mokia-Serbina, S. and Baronio, R. and Brzostek, J. and Kaczmarek, J. (2014) Bronchodilating effects of extrafine beclometasone dipropionate and formoterol fumarate via pressurized metered dose inhaler in asthmatic children. 13th International Congress on Pediatric Pulmonology, Bruges, Belgium, June 26–29, 2014. III. Abstracts. Pediatric Pulmonology, V. 49 (Is.S37). S55-S55. ISSN 8755-6863
|
Text
ppul.23068-S55.pdf Download (42kB) | Preview |
Abstract
Introduction: in asthmatic children older than 5 years, the GINA guidelines 2012 update recommend to add inhaled long-acting b2- agonists (LABA) when the disease is not adequately controlled with inhaled corticosteroids (ICS) alone. Controlled studies have shown that fixed combination therapies are as effective as giving each drug separately and may increase patients’ compliance. A paediatric extrafine fixed combination of beclometasone dipropionate (BDP) and formoterol fumarate (FF) via pressurized metered dose inhaler (pMDI) containing 50mg of BDP and 6mg of FF per actuation (CHF1535) was developed by Chiesi Farmaceutici S.p.A. (Parma, Italy).
| Item Type: | Article |
|---|---|
| Additional Information: | 13th International Congress on Pediatric Pulmonology, Bruges, Belgium, June 26–29, 2014: Volume 49, Issue S37 https://onlinelibrary.wiley.com/doi/10.1002/ppul.23068 (2014), III. Abstracts. Pediatr Pulmonol., 49: S50-S89. doi:10.1002/ppul.23068 Abstracts #82 |
| Subjects: | Pediatrics |
| Divisions: | Faculty of Postgraduate Education > Department of Pediatrics, family medicine and clinical laboratory diagnostics FPE |
| Depositing User: | Елена Шрамко |
| Date Deposited: | 22 May 2020 13:52 |
| Last Modified: | 22 May 2020 14:45 |
| URI: | http://repo.dma.dp.ua/id/eprint/5400 |
Actions (login required)
 |
View Item |
